Pfizer fends off generic Detrol LA from Impax
This article was originally published in Scrip
Executive Summary
Pfizer has confirmed it has settled its patent infringement suit against Impax, which had in 2008 sought to make generic versions of Pfizer's antimuscarinic Detrol LA (tolterodine extended release) for over active bladder.